CAS 464924-27-4

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

CAS: 464924-27-4

SLLK is a control peptide for LSKL.

Formel: C₂₁H₄₁N₅O₆

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 459.58

Ref: TM-TP1833

Sllk, control peptide for tsp1 inhibitor

Kontrolliertes Produkt

CAS: 464924-27-4

Sllk is a control peptide for TSP1 inhibitor that has been shown to induce apoptosis in cancer cells. This peptide is derived from the urine of Chinese patients and has been found to have elastase inhibitory activity. Sllk is an analog of the anticancer kinase inhibitor, which can be used as a tumor suppressor protein. It has been demonstrated that Sllk can inhibit the activity of various kinases involved in cancer progression, making it a promising candidate for future cancer therapies. The use of Sllk as a control peptide for TSP1 inhibitors can help researchers better understand the mechanisms underlying cancer cell growth and may lead to the development of novel anticancer treatments.

Formel: C₂₃H₄₆N₆O₇

Reinheit: Min. 95%

Molekulargewicht: 518.6 g/mol

Ref: 3D-PTA92427